Genetic Signatures Ltd
ASX:GSS
Genetic Signatures Ltd
ASX:GSS
Price:
0.076
AUD
-3.8%
Market Cap:
AU$17.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Genetic Signatures Ltd
ASX:GSS
|
AU |
|
Papa John's International Inc
NASDAQ:PZZA
|
US |
|
E
|
ENEOS Holdings Inc
SWB:JHJ
|
JP |
|
Americas Gold and Silver Corporation
TSX:USA
|
CA |
|
UUUM Co Ltd
TSE:3990
|
JP |
|
IVS Group SA
MIL:IVS
|
IT |
|
R
|
Resmed Inc
ASX:RMD
|
US |
|
Texaf SA
XBRU:TEXF
|
BE |
|
P
|
Paramount Group Inc
NYSE:PGRE
|
US |
|
Sumitomo Mitsui Construction Co Ltd
TSE:1821
|
JP |
|
PTT Oil and Retail Business PCL
SET:OR
|
TH |
|
Linc Ltd
NSE:LINC
|
IN |
|
Torii Pharmaceutical Co Ltd
TSE:4551
|
JP |
|
NCXX Group Inc
TSE:6634
|
JP |
|
Next Hydrogen Solutions Inc.
XTSX:NXH
|
CA |
|
WDB Holdings Co Ltd
TSE:2475
|
JP |
Relative Value
The Relative Value of one
GSS
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 0.076 AUD,
Genetic Signatures Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GSS Relative Value
HIDDEN
Multiples Across Competitors
GSS Competitors Multiples
Genetic Signatures Ltd Competitors
Genetic Signatures Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Genetic Signatures Ltd
ASX:GSS
|
17.3m AUD | 0.7 | -1.5 | 1.1 | 1.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
939.8B USD | 329.1 | 3 896.5 | 1 116.6 | 2 150.2 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
179.9B USD | 4 | 26.8 | 18.7 | 25.1 | |
| US |
|
Danaher Corp
NYSE:DHR
|
134.3B USD | 5.5 | 37.2 | 18.9 | 27.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
32B CHF | 5 | 34.4 | 25.7 | 25.7 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
260B CNY | 5.9 | 17.3 | 17.4 | 17.4 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.7B USD | 4.5 | 24.5 | 18.1 | 21.4 | |
| US |
|
Waters Corp
NYSE:WAT
|
29.6B USD | 9.3 | 46 | 29.7 | 37.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.3B USD | 1.7 | 20.9 | 11.7 | 17.6 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.2B USD | 6.3 | 29 | 21.6 | 24 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
